BlackRock’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-671,529
| Closed | -$6.66M | – | 5711 |
|
|
2023
Q1 | $6.66M | Buy |
671,529
+158,788
| +31% | +$1.57M | ﹤0.01% | 3513 |
|
|
2022
Q4 | $5.11M | Sell |
512,741
-59,571
| -10% | -$444K | ﹤0.01% | 3714 |
|
|
2022
Q3 | $3.15M | Buy |
572,312
+138,134
| +32% | +$766K | ﹤0.01% | 3960 |
|
|
2022
Q2 | $1.58M | Buy |
434,178
+19,832
| +5% | +$93.8K | ﹤0.01% | 4350 |
|
|
2022
Q1 | $2.51M | Buy |
414,346
+1,390
| +0.3% | +$8.47K | ﹤0.01% | 4297 |
|
|
2021
Q4 | $3.48M | Buy |
412,956
+360,905
| +693% | +$3.15M | ﹤0.01% | 4154 |
|
|
2021
Q3 | $472K | Sell |
52,051
-3,304
| -6% | -$28.4K | ﹤0.01% | 4769 |
|
|
2021
Q2 | $449K | Buy |
55,355
+11,640
| +27% | +$79.9K | ﹤0.01% | 4720 |
|
|
2021
Q1 | $241K | Buy |
43,715
+5,579
| +15% | +$27.6K | ﹤0.01% | 4712 |
|
|
2020
Q4 | $129K | Buy |
38,136
+5,481
| +17% | +$14.4K | ﹤0.01% | 4541 |
|
|
2020
Q3 | $56K | Buy |
32,655
+3,574
| +12% | +$5.39K | ﹤0.01% | 4600 |
|
|
2020
Q2 | $48K | Sell |
29,081
-4,872
| -14% | -$9.68K | ﹤0.01% | 4589 |
|
|
2020
Q1 | $65K | Sell |
33,953
-1,548
| -4% | -$4.06K | ﹤0.01% | 4423 |
|
|
2019
Q4 | $101K | Sell |
35,501
-344
| -1% | -$996 | ﹤0.01% | 4449 |
|
|
2019
Q3 | $118K | Sell |
35,845
-1,892
| -5% | -$5.99K | ﹤0.01% | 4416 |
|
|
2019
Q2 | $122K | Buy |
37,737
+11,229
| +42% | +$39.9K | ﹤0.01% | 4435 |
|
|
2019
Q1 | $99K | Buy |
26,508
+2,865
| +12% | +$10K | ﹤0.01% | 4385 |
|
|
2018
Q4 | $81K | Sell |
23,643
-424
| -2% | -$2.09K | ﹤0.01% | 4395 |
|
|
2018
Q3 | $172K | Buy |
24,067
+1,299
| +6% | +$10.1K | ﹤0.01% | 4352 |
|
|
2018
Q2 | $159K | Buy |
22,768
+6,775
| +42% | +$42.1K | ﹤0.01% | 4368 |
|
|
2018
Q1 | $100K | Sell |
15,993
-405
| -2% | -$2.55K | ﹤0.01% | 4347 |
|
|
2017
Q4 | $91K | Buy |
16,398
+648
| +4% | +$2.95K | ﹤0.01% | 4351 |
|
|
2017
Q3 | $73K | Buy |
15,750
+12,873
| +447% | +$68K | ﹤0.01% | 4416 |
|
|
2017
Q2 | $23K | Buy |
2,877
+2,805
| +3,896% | +$22.9K | ﹤0.01% | 4639 |
|
|
2017
Q1 | $1K | Buy |
+72
| New | +$916 | ﹤0.01% | 4981 |
|
BlackRock's APEN Position: Q2 2023 in Review
BlackRock sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 671,529 shares — an estimated $6.66M sold.
BlackRock first reported a position in APEN in Q1 2017 and held it in 25 quarters. The position peaked at $6.66M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.
- BlackRock reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
- BlackRock sold 671,529 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $6.66M.
- BlackRock first reported a position in Apollo Endosurgery, Inc. in Q1 2017 and held it in 25 quarters.
- BlackRock's Apollo Endosurgery, Inc. position peaked at $6.66M in Q1 2023.
- 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.
Based on BlackRock's 13F filing for Q2 2023, filed 11 Aug 2023.